Skip to main content
FAQs
Glossary
Close
FAQs
Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?
See all FAQs
Close
Glossary
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Antibody
Antigen
Base editors
Cas9 nuclease
Chimeric Antigen Receptor (CAR)
Chromosome
Clinical trial
See full Glossary
EuroGCT
Menu
Close
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Main navigation
Discover
Discover
Discover Gene and Cell Therapy
Educational Resources Directory
Educational Resources Directory
INTENS
INtestinal Tissue ENgineering Solution
LEARN
Listening to the experience of participants in neurosurgical trials
Discover Gene and Cell Therapy
Research Pathways
Research Pathways
Bringing new therapies from the lab to patients
EuroGCT Key Resources
EuroGCT Key Resources
ATMP Engage
Advanced Therapy Medicinal Products Patient and Public Involvement and Engagement Working Group
Actors and Network database
Actors and Network database
Bringing new therapies from the lab to patients
About Us
Our team and partners
Contact
Condition
Alzheimer's Disease
Blood disorders
Bowel Disease
Cancer
Cerebral Palsy
Cord Blood
Cystic Fibrosis
Diabetes
Epidermolysis Bullosa
Eye Disease
Heart Disease
Huntington's Disease
Immune Conditions
Kidney Disease
Liver Disease
Lung Disease
Motor Neurone Disease
Multiple Sclerosis
Muscle and Skeletal Diseases
Muscular Dystrophy
Neurological Disorders
Parkinson's Disease
Rare Diseases
Sickle Cell Disease
Skin
Spinal Cord Injuries
Spinal Muscular Atrophy
Stroke
Reproduction and Fertility
Theme
Blood Stem Cells
CAR-T Therapy
Cell and Gene Fundamentals
Cell Therapy
Clinical Trials
Cord Blood
Current and Potential Uses
Disease Modelling
Embryonic Stem Cells
Ethics and Society
Explore Stem Cells
Factsheets
Gene Editing
Gene Therapy
Industry
iPS cells
Methods and Tools
MSCs
Organoids
Patient Involvement
Policy & Regulation
Reprogramming
Research
Skin Stem Cells
Spotlight on Research
Stem Cell News
Tissue Engineering
Unproven Treatments
Search
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Breadcrumb
Home
Resources
Resources
Search within the page or choose from the most common topics below
Theme
Stem Cell News
Current and Potential Uses
Research
Cell and Gene Fundamentals
Blood Stem Cells
CAR-T Therapy
Cell Therapy
iPS cells
Skin Stem Cells
Embryonic Stem Cells
MSCs
Clinical Trials
Patient Involvement
Cord Blood
Explore Stem Cells
Disease Modelling
Gene Editing
Tissue Engineering
Ethics and Society
Factsheets
Gene Therapy
Industry
Policy & Regulation
Unproven Treatments
Methods and Tools
Organoids
Reprogramming
Spotlight on Research
Condition
Stroke
Alzheimer's Disease
Spinal Muscular Atrophy
Eye Disease
Blood disorders
Bowel Disease
Cancer
Cerebral Palsy
Huntington's Disease
Motor Neurone Disease
Parkinson's Disease
Immune Conditions
Kidney Disease
Neurological Disorders
Lung Disease
Rare Diseases
Heart Disease
Muscle and Skeletal Diseases
Liver Disease
Cord Blood
Diabetes
Cystic Fibrosis
Muscular Dystrophy
Epidermolysis Bullosa
Multiple Sclerosis
Skin
Spinal Cord Injuries
Sickle Cell Disease
Reproduction and Fertility
Search by keyword
English
Cut + Paste
English
Your DNA, Your Say
English
British Society for Gene and Cell Therapy: Educational resources
English
Understanding Stem Cells
English
European Reference Networks
Related Topics
Current and Potential Uses
Ethics and Society
Policy & Regulation
NCATS PaVe-GT: Paving the Way for Rare Disease Gene Therapies
NCATS Clinical Research Toolbox
NCATS Assay Guidance Manual
Overview of current GMO regulatory landscape
Process analysis of pluripotent stem cell differentiation to megakaryocytes to make platelets applying European GMP
EATRIS Transmed Academy
UKRI Good research resource hub
UKRI Health Funding Map
UKRI Medimap: End-to-end medicines supply chain
Strategies to identify and mitigate risks for first-in-human and early clinical trials with IMPs
EMA pilot programme
Scientific guideline on the risk-based approach applied to ATMPs
The ISSCR Guide to Stem Cell Treatments
Related Topics
Blood Stem Cells
Cell Therapy
Clinical Trials
Embryonic Stem Cells
Ethics and Society
iPS cells
Patient Involvement
Reprogramming
Skin Stem Cells
Stem Cell News
Compassionate use
Related Topics
Rare Diseases
Cell Therapy
Clinical Trials
Current and Potential Uses
Gene Therapy
Patient Involvement
Policy & Regulation
Unproven Treatments
Gene and cell therapies: an introduction for educators
Pagination
First page
« First
Previous page
‹ Previous
…
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
…
Next page
Next ›
Last page
Last »
Back to top
